By Iain Gilbert
Date: Friday 22 Aug 2025
(Sharecast News) - Hikma Pharmaceuticals revealed on Friday that non-executive director Laura Balan had acquired 3,500 ordinary shares in the FTSE 100-listed drugmaker.
PDMR Dealings | 22-Aug-2025 | 15:36 | RNS |
Holding(s) in Company | 22-Aug-2025 | 12:30 | RNS |
Director/PDMR Shareholding | 22-Aug-2025 | 12:02 | RNS |
Update on licensing and development progress | 22-Aug-2025 | 07:00 | RNS |
Transaction in Own Shares | 22-Aug-2025 | 07:00 | RNS |
Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
Investment Column:BTG | 06-Oct-2011 | The Independent |
Investment Column:Genus | 09-Sep-2011 | The Independent |
Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
Price | 22,315.74 |
Closing Price Change | -92.14 |
% Change | -0.41 % |
22-Aug-25 Close | 22,315.74 |
You are here: research